![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Andersson B.
Publisher: Adis International
ISSN: 1170-229X
Source: Drugs & Aging, Vol.17, Iss.5, 2000-11, pp. : 399-410
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus
Drug Safety, Vol. 20, Iss. 6, 1999-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus
Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Akcay Tulay Dincer Yildiz Kayali Refik Colgar Umur Oral Engrin Cakatay Ufuk
Journal of Toxicology and Environmental Health, Vol. 59, Iss. 1, 2000-01 ,pp. :